160 related articles for article (PubMed ID: 35216166)
1. Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.
Abu-Rumeileh S; Barschke P; Oeckl P; Baiardi S; Mammana A; Mastrangelo A; Al Shweiki MR; Steinacker P; Ladogana A; Capellari S; Otto M; Parchi P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216166
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
Barschke P; Abu-Rumeileh S; Al Shweiki MHDR; Barba L; Paolini Paoletti F; Oeckl P; Steinacker P; Halbgebauer S; Gaetani L; Lewerenz J; Ludolph AC; Landwehrmeyer GB; Parnetti L; Otto M
J Neurol; 2022 Sep; 269(9):5136-5143. PubMed ID: 35737109
[TBL] [Abstract][Full Text] [Related]
3. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
4. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
5. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
Prion; 2013; 7(5):383-93. PubMed ID: 24047819
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
[TBL] [Abstract][Full Text] [Related]
7. A discriminative event-based model for subtype diagnosis of sporadic Creutzfeldt-Jakob disease using brain MRI.
Venkatraghavan V; Pascuzzo R; Bron EE; Moscatelli M; Grisoli M; Pickens A; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Klein S; Bizzi A
Alzheimers Dement; 2023 Aug; 19(8):3261-3271. PubMed ID: 36749840
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
Schmitz M; Llorens F; Pracht A; Thom T; Correia Â; Zafar S; Ferrer I; Zerr I
Aging (Albany NY); 2016 Nov; 8(11):2927-2935. PubMed ID: 27852982
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
[TBL] [Abstract][Full Text] [Related]
10. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.
Llorens F; Kruse N; Karch A; Schmitz M; Zafar S; Gotzmann N; Sun T; Köchy S; Knipper T; Cramm M; Golanska E; Sikorska B; Liberski PP; Sánchez-Valle R; Fischer A; Mollenhauer B; Zerr I
Mol Neurobiol; 2018 Mar; 55(3):2249-2257. PubMed ID: 28321768
[TBL] [Abstract][Full Text] [Related]
11. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
[TBL] [Abstract][Full Text] [Related]
12. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
[TBL] [Abstract][Full Text] [Related]
13. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
[TBL] [Abstract][Full Text] [Related]
14. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
[TBL] [Abstract][Full Text] [Related]
15. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease.
Pascuzzo R; Oxtoby NP; Young AL; Blevins J; Castelli G; Garbarino S; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Alexander DC; Bizzi A
Acta Neuropathol; 2020 Aug; 140(2):169-181. PubMed ID: 32535770
[TBL] [Abstract][Full Text] [Related]
16. Structural signature of sporadic Creutzfeldt-Jakob disease.
Navid J; Day GS; Strain J; Perrin RJ; Bucelli RC; Dincer A; Wisch JK; Soleimani-Meigooni D; Morris JC; Benzinger TLS; Ances BM
Eur J Neurol; 2019 Aug; 26(8):1037-1043. PubMed ID: 30735286
[TBL] [Abstract][Full Text] [Related]
17. Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology.
Gawinecka J; Dieks J; Asif AR; Carimalo J; Heinemann U; Streich JH; Dihazi H; Schulz-Schaeffer W; Zerr I
J Proteome Res; 2010 Nov; 9(11):5646-57. PubMed ID: 20866111
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
[TBL] [Abstract][Full Text] [Related]
20. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.
Tahir W; Zafar S; Llorens F; Arora AS; Thüne K; Schmitz M; Gotzmann N; Kruse N; Mollenhauer B; Torres JM; Andréoletti O; Ferrer I; Zerr I
Mol Neurobiol; 2018 Jan; 55(1):517-537. PubMed ID: 27975168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
